一种Prime-Boost疫苗接种方法诱导了来自中央记忆的CD8+T细胞,从而防止瘤肺转移
Haoran Xu1,2,3, Ming Yue1,3,4, Runhong Zhou1,2,3
1AIDS Institute, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
Cancer research
|October 1, 2024
概括
一种主要增强疫苗策略有效地从中央记忆T细胞 (TCM) 产生肺内存T细胞 (TRM). 这些肺TRM细胞对癌症转移提供了显著的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 癌症研究 癌症研究
背景情况:
- 记忆T细胞对于抗癌免疫是至关重要的.
- 肺组织内存T (TRM) 细胞对转移有保护作用.
- 了解肺TRM细胞的起源可以改善抗转移策略.
研究的目的:
- 为了确定疫苗诱导的肺 CD8+ TRM 细胞的来源.
- 评估一项主要增强疫苗接种策略在产生保护性肺 TRM 细胞方面的有效性.
- 阐明鼻腔内接种促进TRM细胞形成的机制.
主要方法:
- 使用DNA和活衰减型流感载体疫苗 (LAIV) 进行主要增强疫苗接种.
- 流细胞计量量化肺CD8+TRM细胞和循环记忆T细胞.
- 在体内瘤挑战模型 (黑色素瘤,间皮瘤).
- 单细胞RNA测序用于分析T细胞的转录变化.
主要成果:
- 主要增强疫苗接种 (DNA 主要,鼻内LAIV增强) 显著增加了肺 CD8+ TRM 细胞频率.
- 疫苗诱导的肺 CD8+ TRM 细胞,非循环细胞,对肺转移有保护.
- 中心记忆T (TCM) 细胞被确定为肺TRM细胞的前体,在鼻内LAIV增强后.
- 鼻内LAIV诱导了CXCR3依赖的TCM细胞的招募,并启动了TRM细胞分化程序.
结论:
- 中央记忆T细胞是疫苗诱导的肺CD8+TRM细胞的来源.
- 主要增强疫苗接种重新编程TCM细胞,并为TRM细胞生成塑造肺部的微环境.
- 这一策略为预防癌症转移提供了一个有希望的方法.
相关概念视频
Immunological Memory
554
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
554
Vaccinations
44.1K
Overview
44.1K
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Cells of the Adaptive Immune Response
969
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
969
Cell-mediated Immune Responses
67.7K
Overview
67.7K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489


